Evidence map›Paper›PMID 39875398›Full record

Observational studyScientific reports2025

Experience with the implementation of central venous catheters by medical oncologists in a non-surgical setting.

Alfonso Revuelta, Luka Mihic, Alfredo Castillo, Axel Mariño, Lucía Mateos, Claudia Iglesias, Carmen Sáenz de Jubera, Cristina Fernández, David Rodríguez-Rubí, Paula Jiménez-Fonseca and 2 more

Abstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Removal of a broken venous port from the pulmonary artery: a case series.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alfonso RevueltaMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain. revuelta.al@gmail.com.
Luka MihicMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain.
Alfredo CastilloMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain.
Axel MariñoMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain.
Lucía MateosMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain.
Claudia IglesiasMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain.
Carmen Sáenz de JuberaMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain.
Cristina FernándezMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain.
David Rodríguez-RubíMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain.
Paula Jiménez-FonsecaMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain.
José Pablo BerrosMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain.
Emilio EstebanMedical Oncology Department, Central University Hospital of Asturias, Oviedo, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Totally implantable central venous catheters (CVCs) are widely used in the management of patients with malignant diseases. Conventionally, port implantations were carried out by general surgeons and vascular radiologists. In recent years, the medical staff of the Medical Oncology department at the Central University Hospital of Asturias (HUCA) has developed a simplified methodology for the routine implantation of these devices. The aim of this study was to review our experience of CVCs and analyze the outcomes regarding catheter duration, complications, and cost comparison with respect to conventional port implantation by vascular radiologists. An observational epidemiological study was conducted, analyzing the methodology performed in a non-surgical, outpatient setting utilizing the Seldinger technique, without fluoroscopic control. A thorax X-ray was performed after each procedure and no prophylactic antibiotics were required. From January 2015 to March 2019, five hundred port systems were implanted, with a median age of 62 years (range 18-81), male 286/female 214. Most patients had a digestive tumor (79.4%). The right jugular vein was the most accessed in 345 patients (69%), followed by right subclavian in 144 (29%). Complications were observed in 49 patients (9.8%), immediate in 16 (3.2%), and late in 33 (6.6%). Thirty-nine devices were removed (7.8%). The cost incurred for port implantations by medical oncologists was lower (994.38 € cheaper for each device) compared to those implanted by vascular radiologists. Our experience suggests that implantation of port devices by medical oncologist in a non-surgical environment is safe and cost saving regarding conventional procedures.

Indexed as

Catheterization, Central VenousCentral Venous CathetersNeoplasmsOncologistsAdolescentAdultAgedAged, 80 and overFemaleHumansJugular VeinsMaleMiddle AgedYoung AdultCathetersCentralMedicalNon-surgicalOncologistVenous

Identifiers

PMID39875398
PMCPMC11775252

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.